Akèy › Limfòm folikilè › Kalifòni › Los Angeles
Etid klinik pou Limfòm folikilè nan Los Angeles, CA
11 etid pou Limfòm folikilè ap chèche patisipan nan sit nan ak bò kote Los Angeles (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses
Ap rekriteVolontè an sante akeyi
- Community Health Project Los Angeles (CHPLA), Los Angeles
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Ap rekriteFaz 1
- University of California, Los Angeles (UCLA) - Medical Center, Los Angeles
NEO100 and High-Grade Meningioma
Ap rekriteFaz 2
- University of Southern California, Los Angeles
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
Ap rekriteFaz 3
- David Geffen School of Medicine at UCLA, Los Angeles
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Ap rekriteFaz 3
- University of California, Los Angeles, Los Angeles
A Study of ARC-02 in B-cell NHL
Ap rekriteFaz 1
- Start Cala, Los Angeles
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Ap rekriteFaz 1/2
- Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles (UCLA) Medical Center, Los Angeles
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
Ap rekriteFaz 3
- David Geffen School of Medicine at UCLA, Los Angeles
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Ap rekriteFaz 1/2
- Valkyrie Clinical Trials, Los Angeles
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
Ap rekriteFaz 1
- START Los Angele, Los Angeles
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Ap rekriteFaz 1/2
- Los Angeles Cancer Network, Los Angeles
- UCLA Medical Center of Hematology/Oncology, Los Angeles
Etid Limfòm folikilè nan lòt vil
- New York City, NY24 etid
- Milwaukee, WI19 etid
- Nashville, TN18 etid
- Houston, TX18 etid
- Boston, MA17 etid
- Baldwin Park, CA16 etid
- Seattle, WA15 etid
- Durham, NC15 etid
- Columbus, OH13 etid
- Salt Lake City, UT13 etid
- Chicago, IL12 etid
- San Antonio, TX12 etid
Lòt etid nan Los Angeles
- Kansè Poumon ki pa ti selil87 etid
- Kansè (tout kalite)74 etid
- Kansè nan tete73 etid
- Kansè pwostat61 etid
- Kansè kolorektal59 etid
- Kansè Metastatik57 etid
- Kansè ovè50 etid
- Kansè poumon45 etid
- Karsinòm selil skuamèz tèt ak kou42 etid
- Kansè pankreyas35 etid
- Kansè Endomèt34 etid
- Melanom34 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.